Please login to the form below

Not currently logged in
Email:
Password:

Bristol Myers-Squibb launch Best to Test

Bristol Myers-Squibb is sponsoring a new initiative to improve the level of chronic myeloid leukaemia monitoring
Bristol Myers-Squibb is sponsoring a new initiative to improve the level of chronic myeloid leukaemia (CML) monitoring on the back of results of a recent survey that indicate that doctors are not doing enough in this area.

While UK GPs came out top of the poll of 550 physicians and specialists across Europe, the results show that 47 per cent of the respondents are not carrying out regular monitoring for CML patients.

The Best to Test initiative will push forward a drive to change and improve the level and quality of CML monitoring and testing after the data from the survey suggested that better education and support is needed.

"Resistance and intolerance to treatments are real concerns for patients and their physicians and monitoring in the correct way is key to achieving the longest possible survival rates," said Tony Gavin, chief executive of Leukaemia CARE UK.

23rd June 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics